Randomized phase II study of sipuleucel-T (SipT) with or without radium-223 (Ra223) in men with asymptomatic bone-metastatic castrate-resistant prostate cancer (mCRPC)-MedSci.cn - 梅斯（MedSci）

Randomized phase II study of sipuleucel-T (SipT) with or without radium-223 (Ra223) in men with asymptomatic bone-metastatic castrate-resistant prostate cancer (mCRPC)

Marshall, CH; Park, JC; DeWeese, TL; King, S; Afful, M; Hurrelbrink, J; Manogue, C; Cotogno, P; Moldawer, NP; Barata, PC; Drake, CG; Posadas, EM; Armstrong, AJ; Sartor, AO; Antonarakis, ES

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (6):

科室
- - 订阅+
  - 更多科室
工具
服务